A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

NCT01426386 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
265
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals